| 000 | 01722 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513191834.0 | ||
| 264 | 0 | _c19990910 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/91.17.1475 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRebbeck, T R | |
| 245 | 0 | 0 |
_aBreast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cSep 1999 |
||
| 300 |
_a1475-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aEstrogen Replacement Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, BRCA1 _xgenetics |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aOvariectomy |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLevin, A M | |
| 700 | 1 | _aEisen, A | |
| 700 | 1 | _aSnyder, C | |
| 700 | 1 | _aWatson, P | |
| 700 | 1 | _aCannon-Albright, L | |
| 700 | 1 | _aIsaacs, C | |
| 700 | 1 | _aOlopade, O | |
| 700 | 1 | _aGarber, J E | |
| 700 | 1 | _aGodwin, A K | |
| 700 | 1 | _aDaly, M B | |
| 700 | 1 | _aNarod, S A | |
| 700 | 1 | _aNeuhausen, S L | |
| 700 | 1 | _aLynch, H T | |
| 700 | 1 | _aWeber, B L | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 91 _gno. 17 _gp. 1475-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/91.17.1475 _zAvailable from publisher's website |
| 999 |
_c10427266 _d10427266 |
||